Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.

A. D. Watson, J A Berliner, Susan Hama et al. · Journal of Clinical Investigation · 1995 · 1.2K citations · Full text

Life Sciences, Biochemistry, Cell Biology +14

Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein

Michael I. Mackness, Sharon Arrol, Paul N. Durrington · FEBS Letters · 1991 · 978 citations

Life Sciences, Biochemistry, Lipid Biochemistry +16

The molecular basis of the human serum paraoxonase activity polymorphism

Richard Humbert, David A. Adler, Christine M. Distèche et al. · Nature Genetics · 1993 · 840 citations

Life Sciences, Biochemistry, Genetics +4

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase

M MACKNESS, Sharon Arrol, Caroline A. Abbott et al. · Atherosclerosis · 1993 · 816 citations

Life Sciences, Biochemistry, Lipid Biochemistry +14

Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities.

K Gan, Andrew Smolen, H W Eckerson et al. · Drug Metabolism and Disposition · 1991 · 595 citations

Life Sciences, Biochemistry, Molecular Biology +16